NYMXF Alzheimer's treatment! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NYMXF Alzheimer's treatment!

NYMXF 0.106

-0.9%

10:45 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ron who wrote (120)	8/13/1998 6:05:00 PM
From: Demetre Deliyanakis	Read Replies (1) of 132

The recent news on Nymox has been positive. I hope it is not motivated by the sharp decline in its share price since July. The lab fees revenue in the second quarter were $29,384 an increase from 1997's $18,919. This is still low considering the publicity that the company generated in March and April. I wonder when the urine test will be available to the centers.? How much will it cost the company to launch the urine test ? Regards

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next